Abstract:In humans sulfa-2-monomethoxine (S) is metabolized by N4-acetylation (39.9 +/- 8.0 per cent). After an oral dose, S is eliminated biphasically (t1/2, 5.2 +/- 1.6 h and 13.2 +/- 3.4 h) which is similar in both fast and slow acetylators. The metabolite N4-acetylsulfa-2-monomethoxine (N4) is eliminated monophasically (t1/2, 30.0 +/- 5.7 h). The intrinsic mean residence time (MRT) of N4 is 33.5 +/- 8.8 h. The mean total body clearance of S is 11.6 +/- 2.7 ml min-1, and the Vdss is 12.3 +/- 1.01. The renal clearanc… Show more
“…This method is comparable to those already published by this group, e.g. oxazepam glucuronide, temazepam glucuronide [24], codeine-6-glucuronide [25], 5-hydroxysulfapyridine glucuronide [26], sulfadimethoxine-Nl-glucuronide [27], sulfa-6-monomethoxine-N l-glucuronide [28], sulfamethomidine-Nl-glucuronide [29], sulfaphenazole-N2-glucuronide [30], and p-hydroxyphenylphenylhydantoine glucuronide [31].…”
Probenecid with its phase-I metabolites, and phase-II glucuronide conjugate can be analysed by a gradient high pressure liquid chromatographic method. Probenecid glucuronide in plasma with pH 7.4 is not stable and declines to 10% of the original value within 6 h (t1/2 approximately 1 h). Probenecid glucuronide is stable in urine with pH 5.0, moderately unstable at pH 6.0 (t1/2 approximately 10 h), and unstable at pH 8.0 (t1/2 approximately 0.5 h). Probenecid glucuronide is stable in water and 0.01 mol/l phosphoric acid in the autosampler of the high pressure liquid chromatograph. The decrease in concentration in water is 5.5% during 9 h and 0% in diluted acid. Probenecid glucuronide and the phase-I metabolites were not detectable in plasma. The main compound in fresh urine is the phase-II conjugate probenecid glucuronide (62% of a 500 mg dose); the phase-I metabolites are present and only a trace of probenecid is present. The percentage of the dose of the phase-I metabolites varies between 5 and 10, while hardly any probenecid is excreted unchanged (0.33%).
“…This method is comparable to those already published by this group, e.g. oxazepam glucuronide, temazepam glucuronide [24], codeine-6-glucuronide [25], 5-hydroxysulfapyridine glucuronide [26], sulfadimethoxine-Nl-glucuronide [27], sulfa-6-monomethoxine-N l-glucuronide [28], sulfamethomidine-Nl-glucuronide [29], sulfaphenazole-N2-glucuronide [30], and p-hydroxyphenylphenylhydantoine glucuronide [31].…”
Probenecid with its phase-I metabolites, and phase-II glucuronide conjugate can be analysed by a gradient high pressure liquid chromatographic method. Probenecid glucuronide in plasma with pH 7.4 is not stable and declines to 10% of the original value within 6 h (t1/2 approximately 1 h). Probenecid glucuronide is stable in urine with pH 5.0, moderately unstable at pH 6.0 (t1/2 approximately 10 h), and unstable at pH 8.0 (t1/2 approximately 0.5 h). Probenecid glucuronide is stable in water and 0.01 mol/l phosphoric acid in the autosampler of the high pressure liquid chromatograph. The decrease in concentration in water is 5.5% during 9 h and 0% in diluted acid. Probenecid glucuronide and the phase-I metabolites were not detectable in plasma. The main compound in fresh urine is the phase-II conjugate probenecid glucuronide (62% of a 500 mg dose); the phase-I metabolites are present and only a trace of probenecid is present. The percentage of the dose of the phase-I metabolites varies between 5 and 10, while hardly any probenecid is excreted unchanged (0.33%).
“…Recently we were able to measure the N1-glucuronide conjugate of sulphadimethoxine and of sulfa-6-monomethoxine in the urine of man (10,12), but we were unable to find this metabolite in the urine of pigs (6). Instead sulphadimethoxine was completely N4-acetylated.…”
Section: Introductionmentioning
confidence: 84%
“…The parent drug elicits extremely low renal clearance values, suggesting tubular reabsorption. This reabsorption process, followed by N1-glucuronidation, is then a relatively slow process, resulting in the almost identical long half-lives for sulpha-2,6-dimethoxine, sulphamethomidine and sulpha-6-monomethoxine (10,12,17). The reabsorption can be assumed to be carried out by the urate reabsorption pathway, because sulpha-2,6-dimethoxine and urate have some similarities in their molecular structures.…”
Section: A Hypothesis For N1-glucuronidationmentioning
SUMMARY. Pigs are unable to form Ni-glucuronides of sulphadimethoxine and sulphamethomidine, while humans are able to do so. Pigs and humans are able to oxidise sulphapyridine and form the 0-glucuronide. The double conjugate N4-acetylsulphapyridine-0-glucuronide is formed in humans but not in pigs. Sulphadiazine is mainly acetylated in both humans and pigs. A hypothesis about Ni-glucuronidation is presented.
“…The capacity factors of the compounds are respectively: sulpha-2-monomethoxine 4.86, N4-acetylsulpha-2-monomethoxine 6.54, and the unidentified compound at 2.91. Deconjugation Deglucuronidation was carried out by incubating for 6 hours at 37° C using 100 ill tank water, 100 ill of B-glucuronidase (50,000 U/ml type LII, lyophilised powder from limpets Patella vulgata) and 800 Al of potassium dihydrogen phosphate buffer, pH 3.8 (16,17).…”
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.